Marcus M. Goncalves
Joinville, SC, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Reliability in long-term clinical studies of disease-modifying therapies for relapsing-remitting multiple sclerosis: A systematic review.
Journal: PloS one
Published: November 12, 2019
Severe Exacerbation of Multiple Sclerosis Following Withdrawal of Fingolimod.
Journal: Clinical drug investigation
Published: June 02, 2019
Clinicogenetic lessons from 370 patients with autosomal recessive limb-girdle muscular dystrophy.
Journal: Clinical genetics
Published: May 09, 2019
Clinical and molecular findings in a cohort of ANO5-related myopathy.
Journal: Annals of clinical and translational neurology
Published: March 11, 2019
The genetic heterogeneity of hereditary transthyretin amyloidosis in a sample of the Brazilian population.
Journal: Journal of the peripheral nervous system : JPNS
Published: January 15, 2018
No correlation was observed between vitamin D levels and disability of patients with multiple sclerosis between latitudes 18° and 30° South.
Journal: Arquivos de neuro-psiquiatria
Published: August 07, 2016
Cost analysis of multiple sclerosis in Brazil: a cross-sectional multicenter study.
Journal: BMC health services research
Published: February 05, 2015
We know how to prescribe natalizumab for multiple sclerosis, but do we know how to withdraw it?
Journal: Expert review of neurotherapeutics
Published: January 15, 2014
Long-term effects of exposure to disease-modifying drugs in the offspring of mothers with multiple sclerosis: a retrospective chart review.
Journal: CNS drugs
Published: October 12, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026